MetaCap

Nutex Health Inc. (NUTX)

NASDAQ: NUTXConsumer DiscretionaryBusiness ServicesUSD

162.64+0.54 (+0.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

NUTX stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
$23.11
Ex-dividend date
Nov 30, 2026
52-week range
83.99 – 226.16
Day range
155.04 – 165.14
Volume / Avg
157.52K / 149.94K
Beta
—

52-week range

$83.99$226.16

NUTX stock today

On Nov 20, NUTX ended the session at $162.64, adding $0.54 (0.33%), versus the S&P 500's 3.70% decline. Shares are 28.1% below their 52-week high of $226.16, set on Oct 6, 2026 and 93.6% above the 52-week low of $83.99, in the middle of the past year's range. NUTX is down 1.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 18.8%.

At 7.0x trailing earnings, Nutex Health trades below the peer-group median of 31.2x. Its forward P/E of 8.0x is higher than the trailing multiple, which means analysts expect earnings to decline over the next year. To receive the next $2.00 dividend, investors must own shares before the Nov 30 ex-dividend date.

Summary generated from market data by MetaCap's automated system. Methodology

About Nutex Health

Company profile

Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate.

Industry
Business Services
CEO
Dr. Thomas T. Vo M.B.A., M.D.
Headquarters
Houston, TX
Employees
1,093

Financial highlights

Full financials

In fiscal 2025, Nutex Health generated $875.3 million in revenue, up 82.4% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $70.8 million (+35.9% year over year), for a net margin of 8.1% versus a median of 10.9% in the prior 5 years. Gross margin was 50.8% (up from 40.9%) and operating margin 31.5%.

Nutex Health annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$875.26M$479.95M$247.65M$219.29M$331.53M
Growth+82.36%+93.80%+12.93%-33.85%+20.98%
Net income$70.79M$52.10M$-45.79M$-424.78M$132.59M
EPS (diluted)$10.48$9.69$-10.39$-100.36$0.22

Analyst forecast

Forecast

Consensus (6 analysts)

strong_buy

Avg. price target

$313.67+92.86%

  • Strong buy 1
  • Buy 5
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $250.00High $357.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$5.71 vs $5.53
Surprise
+3.25%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$2.00
Ex-dividend date
Nov 30, 2026
Pay date
Dec 14, 2026

NUTX news

All NUTX news

Nutex Health peers

Consumer Discretionary sector
NUTX peer companies
CompanyPrice% ChgMarket capCompare
ANDGAndersen Group Inc. Class A57.85+0.40%$1.14Bvs NUTX
AHGAkso Health Group ADS1.26-1.56%$1.08Bvs NUTX
QNSTQuinStreet Inc.18.49-2.74%$1.06Bvs NUTX
LQDTLiquidity Services Inc.31.87-3.51%$1.00Bvs NUTX
RSKDRiskified Ltd. Class A9.46-1.77%$1.26Bvs NUTX
RDWRRadware Ltd.32.22-4.50%$1.36Bvs NUTX
MAXMediaAlpha Inc. Class A13.50-2.46%$784.00Mvs NUTX
PHRPhreesia Inc.11.41-3.88%$708.23Mvs NUTX

Indexes, lists and sector

Nutex Health stock FAQ

What is Nutex Health's stock price today?

NUTX last traded at $162.64 as of Nov 20, 4:00 PM EST, up 0.33% on the day. Prices are delayed at least 15 minutes.

Does Nutex Health pay a dividend?

Yes. Nutex Health pays $0.00 per share annually. The most recent dividend of $2.00 had an ex-dividend date of Nov 30, 2026.

What is NUTX's P/E ratio?

NUTX trades at a trailing P/E ratio of 7.04 and a forward P/E of 8.00, compared with a median of 31.2 for its closest peers.

Who is Nutex Health's CEO?

Dr. Thomas T. Vo M.B.A., M.D. is the chief executive officer of Nutex Health Inc., which has about 1,093 employees.

Has NUTX ever split its stock?

Yes. The most recent NUTX stock split was a 1-for-10 split on Jul 3, 2024, one of 2 splits on record.

What is the NUTX 52-week high?

The 52-week high for NUTX is $226.16 and the 52-week low is $83.99. The stock is currently 28.1% below its high.

Compare NUTX